Navigation Links
SeraCare Life Sciences Announces Formation of Precision Medicine Unit; Bolsters Leadership with Key Industry Hire
Date:6/9/2015

MILFORD, Mass., June 9, 2015 /PRNewswire/ -- SeraCare Life Sciences, a leading partner to global In Vitro Diagnostics manufacturers, announced the formation of a new business unit focused on the development of technologies and products to help enable the safe and effective expansion of precision medicine-driven diagnostics.  The Molecular and Precision Medicine Business Unit will be tasked with developing innovative solutions to support the accurate and precise use of these advanced diagnostic platforms such as next generation sequencing (NGS) and digital PCR (dPCR).  SeraCare also announced today the hiring of Trevor Brown as the Vice President, Precision Medicine to lead the new business unit.

"For over 30 years, SeraCare has supported diagnostic test developers and clinical testing laboratories with tools to improve the quality and safety of their diagnostic tests.  Given this experience, we are in a unique position to help our customers as they transition to more data-intensive diagnostic methods and embrace new technologies such as next generation sequencing and digital PCR," said Charlie Mamrak, CEO of SeraCare.  "Precision medicine will drive the future growth of the diagnostics industry and I am excited to welcome Trevor to help us realize this vision.  He brings extensive diagnostic industry experience as well as solid scientific strategies for advancing our tools along the path to precision medicine."

Trevor Brown comes to SeraCare from Luminex where he was the Director of Global Clinical Diagnostics Strategy.  In this position, he led the development of the long-term menu strategy for molecular diagnostics platforms and developed go-to-market strategies for precision medicine and laboratory-developed testing solutions.  Prior to this position, Trevor held several program leadership roles in the research immunology business at BD Biosciences.

About SeraCare Life Sciences, Inc.

SeraCare enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result.  Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics.  Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents.  For more information, please visit www.seracare.com and follow SeraCare on Twitter (@SeraCare).

CONTACT: 
Kim Anderson
(508) 244-6429
kanderson@seracare.com


'/>"/>
SOURCE SeraCare Life Sciences
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
2. Anti-Toxoplasma Performance Panel from SeraCare Provides Broad Sample of New, Challenging Material
3. SeraCare Life Sciences Goes Live With SAP
4. SeraCare Life Sciences Acquires KPL
5. Claremont BioSolutions Announces Reagent Supply Agreement with SeraCare Life Sciences
6. Lockheed Martin to Continue Providing Life Sciences Support to NASA
7. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
8. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
9. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
10. A “Fail Fast” Strategy for Lead Optimization Pharmacology and Toxicology, New Xtalks Life Sciences Webinar
11. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/29/2019)... HOUSTON (PRWEB) , ... October 29, 2019 , ... ... firm, is pleased to announce its Silver sponsorship and cold chain validation workshop ... La Jolla Torrey Pines in San Diego, California. , The Biomanufacturing World ...
(Date:10/22/2019)... ... October 22, 2019 , ... Enplug , a leading ... System into its digital signage platform. The collaboration brings one of the most ... users to leverage their existing digital signage networks to quickly disseminate critical safety ...
(Date:10/10/2019)... ... October 09, 2019 , ... The International Society ... FDA, as a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting ... , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, the ... (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) has granted ... the temporary relief of chronic neck and shoulder pain of musculoskeletal origin. , ...
Breaking Biology Technology:
(Date:11/14/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... clinical trial for stem cell treatment of knee osteoarthritis . The first treatment came ... of VetStem Biopharma. , In July of 2019, PSC received FDA approval ...
(Date:11/12/2019)... , ... November 12, 2019 ... ... a global leader in the design and manufacturer of technical ergonomic seating ... and adjustable footrests compliant with Healthier Hospital Initiative guidelines. Established by Practice ...
(Date:11/12/2019)... ... November 12, 2019 , ... The Arnold and ... universities and research institutions for its Instrumentation Grant for Advanced Light-Sheet Microscopy ... million per site for the acquisition of instrumentation, development and maintenance; support for ...
Breaking Biology News(10 mins):